Buy (150 RUB)
Generate QR code
Open Access
Subscription or Fee Access
A clinical case of a continuous course of ulcerative with extra-intestinal manifestations
https://doi.org/10.33667/2078-5631-2024-5-13-17
Abstract
Ulcerative colitis (UC) is one of the most serious and poor-studied problems of modern gastroenterology. This nosology is a diffuse inflammation of the intestinal mucosa, limited to the colon with a predominant lesion of the rectum and sigmoid colon. Due to the progressive nature of the disease, patients require lifelong drug therapy and monitoring. Extra-intestinal manifestations are often found in patients with UC and represent a complex problem that requires the close attention of specialists and the appointment of modern pathogenetically-based treatment, including genetically engineered biological drugs. This clinical observation reflects the importance of early diagnosis of UC with extra-intestinal manifestations – primary sclerosing cholangitis and arthropathy, as well as the effectiveness of treatment with ustekinumab.
About the Authors
G. R. Bikbavova
Omsk State Medical University
Russian Federation
Russian Federation
Bikbavova Galya R. - PhD Med, associate professor of Dept of Hospital Therapy, Endocrinology.
Omsk
V. A. Livzan
Omsk State Medical University
Russian Federation
Russian Federation
Livzan Maria A. - DM Sci (habil.), member of Russian Academy of Sciences, professor, head of Dept of Faculty Therapy and Gastroenterology, rector.
Omsk
V. A. Akhmedov
Omsk State Medical University
Russian Federation
Russian Federation
Akhmedov Vadim A. - DM Sci, professor, head of Dept of Medical Rehabilitation of Additional Professional Education.
Omsk
T. V. Tretyakova
Regional Clinical Hospital
Russian Federation
Russian Federation
Tretyakova Tatiana V. - head of Dept of Gastroenterology.
Omsk
V. A. Voyat
Omsk State Medical University
Russian Federation
Russian Federation
Voyat Victoria Alekseevna - Resident of the Department of Medical Rehabilitation of Additional Professional Education.
Omsk
L. I. Telyatnikova
Clinical and Diagnostic Center ‘Ultramed’
Russian Federation
Russian Federation
Telyatnikova Larisa I. - endoscopist, head of Dept of Endoscopic.
Omsk
References
1. Ivashkin V. T., Shelygin Yu.A., Belousova E. A., Abdulganieva D. I., Alekseeva O. A., Achkasov S. I. and others. Draft clinical recommendations for the diagnosis and treatment of ulcerative colitis. Coloproctology.– 2019.– T. 18.– No. 4.– P. 7–36.
2. Khalif I. L., Shapina M. V., Golovenko A. O., Belousova E. A., Chashkova E. Yu., Lakhin A. V., et al. The course of chronic inflammatory bowel diseases and methods of their treatment, used in the Russian Federation (Results of a multicenter population-based single-stage observational study).//Russian Journal of Gastroenterology, Hepatology, Coloproctology.– 2018.– T. 28.– No. 3.– pp. 54–62.
3. Ungaro R. et al. A treat-to-target update in ulcerative colitis: a systematic review // The American journal of gastroenterology.– 2019.– Т. 114.– № . 6.– С. 874.
4. Belous T. A. Pathomorphology of precancerous conditions of the colon // Russian Journal of Gastroenterology, Hepatology, Coloproctology.– 2002.– T. 12.– No. 4.– pp. 50–55.
5. Belousov Yu. V. Gastroenterology of childhood //Kharkov: Consum.– 2000.– T. 528.– P. 2.
6. Shelygin Yu. A. et al. Clinical recommendations. Crohn's disease (K50), adults // Coloproctology.– 2023.– T. 22.– No. 3.– P. 10–49.
7. Hedin C. R. H. et al. The pathogenesis of extraintestinal manifestations: implications for IBD research, diagnosis, and therapy //Journal of Crohn's and Colitis.– 2019.– Т. 13.– № . 5.– С. 541–554.
8. Parfenov A. I., Kagramanova A. V., Knyazev O. V. Systemic manifestations of inflammatory bowel diseases. // Therapeutic archive.– 2020.– T. 92.– No. 2.– pp. 4–11.
9. Palmela C. et al. Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features //Gut and liver.– 2018.– Т. 12.– № . 1.– С. 17.
10. Benson J. M. et al. Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders //MAbs.– Taylor & Francis, 2011.– Т. 3.– № . 6.– С. 535–545.
11. Karlsen T. H. et al. Primary sclerosing cholangitis–a comprehensive review //Journal of hepatology.– 2017.– Т. 67.– № . 6.– С. 1298–1323.
12. Karlsen T. H., Boberg K. M. Update on primary sclerosing cholangitis //Journal of hepatology.– 2013.– Т. 59.– № . 3.– С. 571–582.
13. Peyrin-Biroulet L. et al. Systematic review of tumor necrosis factor antagonists in extraintestinal manifestations in inflammatory bowel disease //Clinical Gastroenterology and Hepatology.– 2017.– Т. 15.– № . 1.– С. 25–36. e27.
14. Kulkarni C. et al. Association of anti-TNF therapy with increased risk of acute cholangitis in patients with primary sclerosing cholangitis //Inflammatory Bowel Diseases.– 2021.– Т. 27.– № . 10.– С. 1602–1609.
15. Guillo L. et al. Ustekinumab for extra-intestinal manifestations of inflammatory bowel disease: a systematic literature review //Journal of Crohn's and Colitis.– 2021.– Т. 15.– № . 7.– С. 1236–1243.
16. Hirschfield G. M. et al. Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study //Hepatology.– 2016.– Т. 64.– № . 1.– С. 189–199.
Review
For citations:
Bikbavova G.R., Livzan V.A., Akhmedov V.A., Tretyakova T.V., Voyat V.A., Telyatnikova L.I. A clinical case of a continuous course of ulcerative with extra-intestinal manifestations. Medical alphabet. 2024;(5):13-17. (In Russ.) https://doi.org/10.33667/2078-5631-2024-5-13-17
Views:
257
Email this article 